Application of a novel Active Allothetic Place Avoidance task (AAPA) in testing a pharmacological model of psychosis in rats: Comparison with the Morris Water Maze

Neuroscience Letters

Volumn 366, Issue 2, 2004, Pages 162-166

  Stuchlik, Ales ^a   Rezacova, Lenka ^a   Vales, Karel ^a   Bubenikova, Vera ^b   Kubik, Stepan ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

Animal model of schizophrenia; Dizocilpine; MK 801; NMDA receptor blockade; Spatial navigation

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; LEARNING; MAZE TEST; MEMORY; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; RAT; STIMULUS; TASK PERFORMANCE;

ANIMALS; AVOIDANCE LEARNING; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; MAZE LEARNING; PSYCHOTIC DISORDERS; RATS; RATS, LONG-EVANS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 3242784115     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.05.037     Document Type: Article

References (22)

1. Adriani W., Felici A., Sargolini F., Roullet P., Usiello A., Oliverio A., Mele A. N-Methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes. Exp. Brain Res. 123:1998;52-59
2. Andine P., Widermark N., Axelsson R., Nyberg G., Olofsson U., Martensson E., Sandberg M. Characterization of MK-801-induced behavior as a putative rat model of psychosis. J. Pharmacol. Exp. Ther. 290:1999;1393-1408
3. Ashe P.C., Berry M.D., Boulton A.A. Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents. Prog. Neuropsychopharmacol. Biol. Psychiatry. 25:2001;691-707
4. Bakker C., Amini F. Observations on the psychotomimetic effects of Sernyl. Comp. Psychiatry. 2:1961;269-280
5. Bannerman D.M., Good M.A., Butcher S.P., Ramsay M., Morris R.G. Distinct components of spatial learning revealed by prior training and NMDA receptor blockade. Nature. 378:1995;182-186
6. Cain D.P., Saucier D., Hall J., Hargreaves E.L., Boon F. Detailed behavioral analysis of water maze acquisition under APV or CNQX: contribution of sensorimotor disturbances to drug-induced acquisition deficits. Behav. Neurosci. 110:1996;86-102
7. Carey R.J., Dai H., Gui J. Effect of dizocilpine (MK-801) on motor activity and memory. Psychopharmacology (Berl.). 137:1998;241-246
8. Cimadevilla J.M., Wesierska M., Fenton A.A., Bures J. Inactivating one hippocampus impairs avoidance of a stable room-defined place during dissociation of arena cues from room cues by rotation of the arena. Proc. Natl. Acad. Sci. U.S.A. 98:2001;3531-3536
9. Deutsch S.I., Rosse R.B., Billingslea E.N., Bellack A.S., Mastropaolo J. Topiramate antagonizes MK-801 in an animal model of schizophrenia. Eur. J. Pharmacol. 449:2002;121-125
10. Farber N.B. The NMDA-receptor hypofunction model of psychosis. Ann. N.Y. Acad. Sci. 1003:2003;119-130
11. Fenton A.A., Arolfo M.P., Nerad L., Bures J. Interhippocampal synthesis of lateralized place navigation engrams. Hippocampus. 5:1995;16-24
12. Fenton A.A., Bures J. Place navigation in rats with unilateral tetrodotoxin inactivation of the dorsal hippocampus: place but not procedural learning can be lateralized to one hippocampus. Behav. Neurosci. 107:1993;552-564
13. Fenton A.A., Bures J. Interhippocampal transfer of place navigation monocularly acquired by rats during unilateral functional ablation of the dorsal hippocampus and visual cortex with lidocaine. Neuroscience. 58:1994;481-491
14. Fenton A.A., Wesierska M., Kaminsky Yu., Bures J. Both here and there: simultaneous expression of autonomous spatial memories in rats. Proc. Natl. Acad. Sci. U.S.A. 95:1998;11493-11498
15. Krystal J., Harper L., Seibyl J., Freeman G., Delancy D., Bremner J., Heninger G., Bowers M. Jr., Charney D. Subanesthetic effect of the noncompetitive NMDA antagonist, ketamine, in humans. Arch. Gen. Psychiatry. 51:1994;199-214
16. Luisada P., Brown B. Clinical management of the phencyclidine psychosis. Clin. Toxicol. 9:1976;539-554
17. Maj J., Rogoz Z., Skuza G. Locomotor hyperactivity induced by MK-801 in rats. Pol. J. Pharmacol. Pharm. 43:1991;449-458
18. Martin P., Swensson A., Carlsson A., Carlsson M.L. On the roles of dopamine D-1 vs. D-2 receptors for the hyperactivity response elicited by MK-801. J. Neural Trans. Gen. Sect. 95:1994;113-121
19. Mittelstaedt M.L., Mittelstaedt H. Homing by path integration in a mammal. Naturwissenshaften. 68:1980;566
20. Ninan I., Kulkarni S.K. Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801. Ind. J. Physiol. Pharmacol. 42:1998;375-382
21. J. O'Keefe, L. Nadel, The Hippocampus as a Cognitive Map, Clarendon, London, 1978, 600 pp.
22. Ylinen A., Pitkanen M., Sirvio J., Hartikainen T., Sivenius J., Koivisto E., Riekkinen P.J. Sr. The effects of NMDA-receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task. Eur. J. Pharmacol. 274:1995;159-165